Your browser doesn't support javascript.
loading
Galangin (GG) combined with cisplatin (DDP) to suppress human lung cancer by inhibition of STAT3-regulated NF-κB and Bcl-2/Bax signaling pathways.
Yu, Shuo; Gong, Lian-Sheng; Li, Nian-Feng; Pan, Yi-Feng; Zhang, Lun.
Afiliação
  • Yu S; Department of General Surgery, Xiangya Hospital, Central South University, Xiangya Road 87, 410008, Changsha, Hunan Province, China.
  • Gong LS; Department of General Surgery, Xiangya Hospital, Central South University, Xiangya Road 87, 410008, Changsha, Hunan Province, China. Electronic address: lianshenggonglw@sina.com.
  • Li NF; Department of General Surgery, Xiangya Hospital, Central South University, Xiangya Road 87, 410008, Changsha, Hunan Province, China.
  • Pan YF; Department of General Surgery, Xiangya Hospital, Central South University, Xiangya Road 87, 410008, Changsha, Hunan Province, China.
  • Zhang L; Department of General Surgery, Xiangya Hospital, Central South University, Xiangya Road 87, 410008, Changsha, Hunan Province, China.
Biomed Pharmacother ; 97: 213-224, 2018 Jan.
Article em En | MEDLINE | ID: mdl-29091869

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / NF-kappa B / Fator de Transcrição STAT3 / Proteína X Associada a bcl-2 / Neoplasias Pulmonares Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Biomed Pharmacother Ano de publicação: 2018 Tipo de documento: Article País de afiliação: China País de publicação: França

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / NF-kappa B / Fator de Transcrição STAT3 / Proteína X Associada a bcl-2 / Neoplasias Pulmonares Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Biomed Pharmacother Ano de publicação: 2018 Tipo de documento: Article País de afiliação: China País de publicação: França